COYA - CIK 0001835022
The table below shows Coya Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $50.72M | $28.13M | $29.76M | $35.53M | $31.06M | $36.58M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $53.26M |
| $32.02M |
| $33.43M |
| $38.37M |
| $35.51M |
| $39.89M |
| Property, plant & equipment | $8.42K | $18.07K | $24.91K | $31.75K | $45.43K | $52.27K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $53.27M | $32.04M | $33.45M | $38.40M | $35.55M | $39.94M |
| Accounts payable | $948.19K | $1.11M | $931.34K | $1.69M | $336.72K | $1.88M |
| Total current liabilities | $3.55M | $3.67M | $4.50M | $4.34M | $2.32M | $3.83M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $4.30M | $4.76M | $5.14M | $5.04M | $3.54M | $4.68M |
| Retained earnings | -$69.17M | -$56.25M | -$54.14M | -$48.04M | -$37.82M | -$33.80M |
| Total equity | $48.97M | $27.28M | $28.31M | $33.37M | $32.01M | $35.26M |